Bank of New York Mellon’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-423,337
| Closed | -$9.19M | – | 4358 |
|
|
2017
Q2 | $9.19M | Sell |
423,337
-37,777
| -8% | -$820K | ﹤0.01% | 2015 |
|
|
2017
Q1 | $6.47M | Buy |
461,114
+26,039
| +6% | +$365K | ﹤0.01% | 2197 |
|
|
2016
Q4 | $8.16M | Buy |
435,075
+81,869
| +23% | +$1.54M | ﹤0.01% | 2061 |
|
|
2016
Q3 | $5.83M | Sell |
353,206
-19,279
| -5% | -$318K | ﹤0.01% | 2163 |
|
|
2016
Q2 | $5.01M | Sell |
372,485
-14,081
| -4% | -$189K | ﹤0.01% | 2210 |
|
|
2016
Q1 | $5.91M | Buy |
386,566
+25,281
| +7% | +$387K | ﹤0.01% | 2093 |
|
|
2015
Q4 | $7.17M | Sell |
361,285
-5,642
| -2% | -$112K | ﹤0.01% | 2013 |
|
|
2015
Q3 | $6.39M | Buy |
366,927
+65,085
| +22% | +$1.13M | ﹤0.01% | 2096 |
|
|
2015
Q2 | $6.1M | Buy |
301,842
+47,174
| +19% | +$954K | ﹤0.01% | 2237 |
|
|
2015
Q1 | $4.48M | Buy |
254,668
+47,335
| +23% | +$833K | ﹤0.01% | 2367 |
|
|
2014
Q4 | $3.38M | Sell |
207,333
-33,277
| -14% | -$542K | ﹤0.01% | 2527 |
|
|
2014
Q3 | $5.31M | Buy |
240,610
+40,487
| +20% | +$894K | ﹤0.01% | 2277 |
|
|
2014
Q2 | $4.03M | Buy |
200,123
+71,601
| +56% | +$1.44M | ﹤0.01% | 2446 |
|
|
2014
Q1 | $2.39M | Sell |
128,522
-87,998
| -41% | -$1.64M | ﹤0.01% | 2773 |
|
|
2013
Q4 | $2.18M | Buy |
216,520
+15,578
| +8% | +$157K | ﹤0.01% | 2832 |
|
|
2013
Q3 | $2.59M | Buy |
200,942
+26,451
| +15% | +$341K | ﹤0.01% | 2682 |
|
|
2013
Q2 | $2.07M | Buy |
+174,491
| New | +$2.07M | ﹤0.01% | 2764 |
|